// company-profile
TScan Therapeutics, Inc.
TCRXExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings57Insiders21
// api This TScan Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, TScan Therapeutics, Inc. insiders bought $0 across 7 transactions with no open-market sales.
- Most active insider: BAKER BROS. ADVISORS LP with 2 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of TScan Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$31.9M
QoQ change
+11.6%
Reporting period
2026-03-31
#1
Lynx1 Capital Management LP
CIK 1910456
$8.1M
8.0M shares
#2
BVF INC/IL
CIK 1056807
$5.6M
5.6M shares
#3
BAKER BROS. ADVISORS LP
CIK 1263508
$2.8M
2.8M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | BAKER BROS. ADVISORS LP | TCRX | Award | 67,000 | $0.00 | $0K |
| May 20, 2026 | BAKER BROS. ADVISORS LP | TCRX | Award | 67,000 | $0.00 | $0K |
| May 20, 2026 | Dorton Katina | TCRX | Award | 67,000 | $0.00 | $0K |
| May 20, 2026 | Gruia Gabriela | TCRX | Award | 67,000 | $0.00 | $0K |
| May 20, 2026 | Klencke Barbara | TCRX | Award | 67,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.